mGuard®
Multi-Gene Methylation Liquid Biopsy Technology
mGuard® technology, also known as Methylation-Magnified Multi-Target Detection technology, efficiently captures multiple gene loci, effectively capturing and amplifying trace amounts of methylation signals in the blood.
Broad Detection Spectrum: Capable of identifying methylation in 3-20 genes simultaneously.
Precision in Detection Outcomes: Minimizes interference between genes and targets for accurate results.
High Detection Sensitivity: Achieves a detection limit as low as 0.05%
Rapid turnaround time: Three day workflow.